DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
Methylsulfanylpyridine based diheteroaryl isocombretastatin analogs as potent anti-proliferative agents
22 p.-7 fig.-2 tab., Isocombretastatins are the not isomerizable 1,1-diarylethene isomers of combretastatins. Both families of
antimitotics are poorly soluble and new analogs with improved water solubility are needed. The ubiquitous
3,4,5-trimethoxyphenyl ring and most of its replacements contribute to the solubility problem. 39 new compounds belonging to two series of isocombretastatin analogs with 2-chloro-6-methylsulfanyl-4-pyridinyl or 2,6-bis(methylsulfanyl)-4-pyridinyl moieties replacing the 3,4,5-trimethoxyphenyl have been synthesized and their antimitotic activity and aqueous solubility have been studied. We show here that 2-chloro-6-methylsulfanylpyridines are more successful replacements than 2,6-bis(methylsulfanyl)pyridines, giving highly potent tubulin inhibitors and cytotoxic compounds with improved water solubilities.The optimal combination is with indole rings carrying polar substitutions at the three position.The resulting diheteroaryl isocombretastatin analogs showed potent cytotoxic activity against human cancer cell lines caused by tubulin inhibition, as shown by in vitro tubulin polymerization inhibitory assays, cell cycle analysis, and confocal microscopy studies. Cell cycle analysis also showed apoptotic responses following G2/M arrest after treatment. Conformational analysis and docking studies were applied to propose binding modes of the compounds at the colchicine site of tubulin and were in good agreement with the observed SAR. 2-Chloro-6-methylsulfanylpyridines represent a new and successful trimethoxyphenyl ring substitution for the development of improved colchicine site ligands., This work was supported by the Consejería de Educación de la Junta de Castilla y León (SA030U16 and SA262P18), co-funded by the EU’s European Regional Development Fund-FEDER, and the Spanish Ministry of Science, Innovation, and Universities (RTI2018-099474-B-I00 and SAF2017-89672-R)., Peer reviewed